Zymeworks, Inc. (ZYME)
22.51
-0.21
(-0.92%)
USD |
NASDAQ |
Feb 09, 16:00
22.59
+0.08
(+0.36%)
Pre-Market: 08:28
Zymeworks EPS Diluted (Quarterly) : -0.2587 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 4.081 |
| Johnson & Johnson | 2.098 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.60M |
| Revenue (Quarterly) | 27.61M |
| Total Expenses (Quarterly) | 47.22M |
| Enterprise Value | 1.464B |
| Gross Profit Margin (Quarterly) | 90.64% |
| Profit Margin (Quarterly) | -70.99% |
| Earnings Yield | -3.76% |
| Normalized Earnings Yield | -3.751 |